Singapore markets close in 2 hours 51 minutes
Straits Times Index
3,310.33 +13.44 (+0.41%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,457.11 +249.98 (+1.37%) FTSE 100
8,172.15 +50.91 (+0.63%) Bitcoin USD
59,539.05 +2,017.95 (+3.51%) CMC Crypto 200
1,281.83 +4.86 (+0.38%)
ABT May 2024 118.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 01:55PM EDT. Market open.
| Previous close | 8.86 |
| Open | 9.04 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 118.00 |
| Expiry date | 2024-05-03 |
| Day's range | 8.86 - 9.04 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksIs Trending Stock Abbott Laboratories (ABT) a Buy Now?
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
ZacksPBH vs. ABT: Which Stock Is the Better Value Option?
PBH vs. ABT: Which Stock Is the Better Value Option?
PR NewswireAbbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.
© 2024 Yahoo. All rights reserved.